Add Email Alerts
close Add Email Alerts DialogYou are adding the following journals to your email alerts
Journal Description
Journal Highlights
- Launched in 2007
- Gold open access journal – all articles are made freely available online immediately upon publication
- Rigorous peer review
- Listed in PubMed and indexed in Web of Science, Science Citation Index Expanded (SCIE), Scopus and MEDLINE
- Over 200 000 full-text article views annually
Therapeutic Advances in Respiratory Disease (TARD) is a peer-reviewed open access journal which focuses on pioneering efforts and innovative studies across all areas of respiratory disease. Please see the Aims and Scope tab for further information.
This journal is a member of the Committee on Publication Ethics (COPE).
Submission information
Submit your manuscript today at http://mc.manuscriptcentral.com/tar.
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Open access article processing charge (APC) information
Unsolicited manuscripts submitted to Therapeutic Advances in Respiratory Disease are subject to an Article Processing Charge (APC) of 2300 USD (+VAT where applicable) payable upon acceptance. These articles will be published under a Creative Commons licence and will be made openly available.
The article processing charge (APC) is payable only if your article is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.
Contact
Please direct any queries to [email protected]
Description
Aims and Scope
Editorial Board
Abstracting/Indexing
Submit Paper